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Abstract 
 
Purpose.    Sleep  disturbance affects a high proportion of people  with fibromyalgia  syndrome  (FMS). This  
study  aims  to explore people’s perceptions of their sleep quality and the influence  sleep has on their symptoms  
and daily lives. 
 
Method.   Semi-structured interviews were conducted with sixteen participants diagnosed  with primary  FMS,  
covering  all aspects  of the  sleep experience.  The  audio  recorded qualitative  interviews  were transcribed 
verbatim  and  analysed  using interpretative phenomenological analysis. 
 
Results.    Poor  sleep dominated participants’  lives, affecting levels of pain  and  fatigue,  engagement in daily 
activities and ability to cope.  Participants reported  experiencing  blocks of sleep, with the most  profound 
difficulty for participants being able to go back to sleep after a night time awakening.  They also felt a lack of 
control  in their ability to manage  their sleep difficulties and  use of day-time  napping  appeared  to be the only 
perceived  beneficial coping  strategy for relieving daytime sleepiness  and symptoms  of fatigue. 
 
Conclusions. Greater  emphasis  on screening  for sleep disorders  and how to manage  poor sleep is needed  in 
rehabilitation programmes provided  for patients  with FMS. 
 
 
 
Introduction 
 
Fibromyalgia  syndrome  (FMS)  is a chronic  condi- 
tion  of unknown  aetiology,  although  emerging 
evidence suggests a disruption to the neurotransmit- 
ters in the central  nervous  system and/or  dysregula- 
tion  of the sympathetic  nervous  system [1].  FMS  is 
characterised by the experience of persistent wide- 
spread  pain (for 43 months) and self-reported pain 
in  ;::11  of  18  tender   points  on  digital  palpitation 
(with the amount of pressure  sufficient to blanch a 
finger nail). Other  symptoms  include  fatigue, cogni- 
tive dysfunction  (such as difficulty concentrating and 
word retrieval) and sleep disturbance [2]. These 
symptoms   can  have  a  disabling  effect  on  people’s 
lives,  with  many  people   forced  to  leave  work  or 
reduce  their  working  hours  because  of their  symp- 
toms  [3].  Population estimates   have  revealed  that 
FMS may affect up to 11% of the general population 
[2,4–6]  and  is associated  with  high  individual  and 
societal health care costs [7–9]. Longitudinal studies 
of patients  with FMS  have revealed that over half of 
patients  receiving standard medical  care report  only 
slight improvement, no change  or a deterioration in 
their symptoms  3 years later [10]. 
 
Poor   sleep  quality  is  a  significant   problem   for 
people   with  chronic   pain  conditions  [11]  and  in 
patients  with  FMS  the  prevalence  of  sleep  distur- 
bances is even higher, with up to 99% of participants 
reporting  some form of sleep disturbance [12,13]. 
People  with  FMS  have  also  been  found  to  be  five 
times  more  likely to have insomnia  than  a compar- 
ison group of patients  with rheumatoid arthritis [14]. 
The  implications  of poor sleep quality are profound, 
with poor sleep linked to increased  morbidity,  risk of 
accidents,  absenteeism from  work,  increased  health 
care  costs  and  mortality  [15,16]. For  people  with 
FMS  the  effects of poor  sleep  may also exacerbate 
other symptoms such as pain, fatigue, cognitive 
impairment and  lead  to  difficulties  in  maintaining
 
 
  
 
social  relationships   and  engaging  in  rehabilitation 
[12,17]. 
Extensive research has explored the quality of sleep 
using  objective  measures  such  as polysomnography 
and has revealed that people with FMS have increased 
stage 1 light sleep [18] and less stage 4 slow wave sleep 
[19,20]. People  with  FMS  are  more  easily awoken 
[21] and compared to healthy controls have higher 
levels of physical activity during  the night [22,23]. A 
longitudinal study exploring sleep and pain in patients 
with FMS  over the course of 1 year, found that poor 
sleep quality  at baseline  was predictive  of pain  and 
sleep quality at 1 year, but baseline pain did not 
significantly predict sleep quality at 1 year [24]. Sleep 
disturbance may therefore  have an important role in 
both the aetiology and maintenance of symptoms  for 
patients with FMS. 
Previous studies  using quantitative research  meth- 
ods have provided a useful overview of the scope and 
nature  of sleep difficulties in people with FMS. 
However, as sleep quality is primarily a subjective 
experience,  understanding what poor sleep means to 
people with FMS  and how it affects their daily lives, 
is essential  to inform  how rehabilitation can address 
patients’  needs.  To  increase  our  understanding  of 
the  sleep  difficulties  people  with  FMS   experience 
and the impact sleep has on their daily living, a 
qualitative  approach  is needed  to  explore  the 
phenomena in more detail. 
Despite the high prevalence of sleep disturbance in 
FMS,  poor sleep quality often receives little attention 
in current  treatment of the  condition. If poor  sleep 
quality is addressed, the most common treatment 
approach  is the prescription of hypnotic or tricyclic 
antidepressant medications. Clinical trials have de- 
monstrated the efficacy of these medications to reduce 
symptoms  of sleep disturbance in the short term. 
However, there is little evidence of the efficacy of 
medications after prolonged use and treatment effects 
often disappear  after discontinuation and may result 
in ‘rebound insomnia’  that  can  lead to dependence 
[25].  Common side effects of hypnotic  and  tricyclic 
medication (such  as drowsiness  and  confusion)  can 
also exacerbate other symptoms of the condition such 
as fatigue and  cognitive  difficulties  and  may not  be 
well tolerated  by some patients [26,27]. 
Because of the complex nature  of symptom pre- 
sentation  in FMS  and limitations  of current  pharma- 
cological treatments, current  management guidelines 
suggest the need for a multi-disciplinary treatment 
approach  [28–30]  to improve  patient  outcomes and 
quality of life. However, a greater understanding of 
sleep difficulties in FMS  is needed  to inform specific 
recommendations as to how sleep disturbance can be 
effectively managed  in this population. 
The   interpretative  phenomenological  approach 
(IPA)  aims to explore  how participants make  sense 
of their world and the meaning  that experiences  have 
for them  and is ‘ideally suited  to exploring  topics in 
health, social and clinical psychology where there is a 
need to discern how people perceive and understand 
events in their lives’ (p. 36) [31].  The  IPA approach 
has not previously been used in FMS.  To expand  on 
previous quantitative findings, this study aims to 
increase understanding of the meaning  that sleep has 
for patients  and the impact of poor sleep on patient’s 
everyday lives using IPA. 
 
 
Methods 
 
Participants 
 
The  IPA  approach  aims  to identify  the  commonal- 
ities of people  experiencing  a specific phenomenon 
and therefore participants are purposively sampled to 
ensure  that  they can  offer a meaningful  perspective 
on the phenomenon being investigated [32]. For this 
study,  participants  were  purposively  recruited 
through  FMS support  groups in the South-East of 
England.   They   were  given  an  information  sheet 
about the study and also offered verbal information 
through   presentations  at  support   group  meetings, 
and   those   interested  in  the  study  were  asked  to 
contact  the researcher. Participants were advised that 
they did not have to be experiencing  sleep difficulties 
to take part in the study, to enable the exploration  of 
the  effect  of  both  good  and  poor  sleep  quality  in 
FMS.   Individuals   were   included    if  they   had   a 
diagnosis   of  FMS   and  were  aged  over  18  years. 
People were excluded  if they were unable to speak or 
understand English or if they had a diagnosed  sleep 
disorder  with an underlying  physical cause (such  as 
sleep apnoea or restless legs syndrome). After 
confirming   that  the  participants  had  received  and 
read the participant information sheet and had been 
given the opportunity to ask any questions  they had 
about   the  study,  a  mutually   convenient   time  was 
arranged  to  conduct the  interview.  The  study 
received   ethical   approval   from   the   University   of 
Surrey Committee of Ethics. 
 
 
Data collection 
 
A brief semi-structured interview schedule  was devel- 
oped  to  guide  the  interview  asking  broad  questions 
about  the  participant’s   illness,  symptom  experience 
and daytime functioning (Table I). The schedule 
developed by the authors (who are both Chartered 
Psychologists)   enabled   the   interviewer   to   explore 
areas relating to the research question, while providing 
the  flexibility  for  the  participant  to  talk  about  the 
issues  that   were  important  to  them   and   for  the 
  
 
Table  I. Interview schedule. 
 
Illness experience  – how would you describe  your quality of life 
with fibromyalgia? 
Diagnosis  e.g. how did you receive a diagnosis? 
Description of symptoms  e.g. what are your main fibromyalgia 
symptoms? 
Impact  on everyday living e.g. what affect does having 
fibromyalgia have on your life? 
Perceived cause e.g. what do you believe to be the cause of your 
fibromyalgia? 
Sleep quality – How would you describe the quality of your sleep? 
Description of sleeping pattern  e.g. when would you usually go 
to bed? 
Description of a typical daily routine  e.g. could  you describe  a 
typical day living with fibromyalgia? 
Description of evening routine  e.g. could you describe a typical 
evening when you are preparing  to go to bed? 
Causes  of poor sleep e.g. what affects your sleep quality? 
Management of Symptoms  – how do you cope with your 
fibromyalgia symptoms? 
Coping  e.g. what do you do if you can’t get to sleep? 
Effect of quality of life e.g. how does your sleep quality affect 
you? 
Support e.g. what support  have you received? 
 
 
 
researcher to explore interesting concepts emerging 
during  the  interview.  All  the  interviews  were  con- 
ducted  by one of the authors  (AT)  within the 
participant’s  home. All interviews were recorded using 
a digital voice recorder  and later transcribed verbatim. 
 
 
Data analysis 
 
The data were analysed and coded using the 
recommended IPA approach  [32].  Two  researchers 
analysed  the  interviews  independently.  The   inter- 
view    transcripts   were    read    several    times    to 
increase familiarity with the data, and preliminary 
interpretations were noted  in the  margin.  The 
approach  acknowledges that the researcher plays an 
active part in interpreting people’s experiences  and 
identifying  underlying  concepts  that  the  participant 
may articulate  but  may not  be consciously  aware of 
[31]. 
Emerging themes were identified from the coded 
notes and discussed between the two researchers. 
Themes were then  clustered  together  and  reapplied 
to the interview  transcripts, noting  any inconsisten- 
cies  between   participants  and   exploring   negative 
cases  [33].  The  overarching   and  sub-themes were 
then  formed  from the identified  subthemes. 
 
 
Results 
 
A sample  of 16  participants took  part  in the  inter- 
views (14 females and  2 males)  that  lasted  between 
20  and  65 min.  As the  aim  of IPA  is to  obtain  a 
detailed understanding of individuals’ personal 
experiences  small samples  are used  so that  such  an 
in-depth  analysis  is feasible  [34].  Participants  were 
aged  between  21  and  61  years  (mean  age ¼ 50.95 
years, SD: 11.94).  All participants had completed 
secondary  education, with 31.25%  of them attending 
college or university. Only one participant was in full 
time  employment, five were working part-time, five 
were retired  and five were no longer working due to 
ill-health.  The  mean  duration of fibromyalgia symp- 
toms  was 17.25  years (SD:  14.77)  with an  average 
length  of  time  since  diagnosis  of  4.13  years  (SD: 
4.37).  Most  participants were  using  some  form  of 
pain relieving medication on a regular basis (62.5%) 
and just over half of participants were prescribed 
medication to aid sleep (56.3%). 
The   interviews   with   participants  revealed   four 
overarching   themes:   (1)   sleep   disturbances,  (2) 
inter-relationship  between   symptoms,   (3)   coping 
with disturbed sleep, and (4) impact  on daily living. 
Each theme  encompassed subordinate themes which 
are  outlined  below  and  illustrated  by direct  quota- 
tions from the interview transcripts. 
 
 
Theme 1: sleep disturbance 
 
Onset of poor sleep. There  was considerable individual 
variability in the onset of sleep difficulties. Four 
participants reported  experiencing   sleep  difficulties 
for  most   of  their  life,  six  participants  could   not 
identify when their difficulties started and six 
participants described that their sleep difficulties 
occurred around  the time of onset of other fibro- 
myalgia symptoms; 
 
‘I don’t  know what  other  reason  there  could  be,  other 
than  the fact that I’m less active now than  I used  to be 
you  know,  but  you  know  it  seems  to  have  come  on 
roughly about  the same time’. 
 
Existence of possible  sleep disorder. Three  participants 
described  experiences  that were indicative of a sleep 
disorder  that  had  not  been  diagnosed  such  as 
bruxism,  sleep walking and restless legs syndrome; 
 
‘You toss and  turn,  you can’t keep still, I’m not  being 
funny  but  my legs have spasms,  they just jump  around 
like someone’s  putting   an  electric  shock  through   you 
every 5 seconds,  your limbs jump and twitch’. 
 
 
Blocks of sleep. It became  apparent  that the main 
difficulties participants experienced with their sleep 
were waking up during the night and feeling un- 
refreshed the following day. Fifteen of the 16 
participants  described   waking  up  several  times   a 
night on a regular basis that caused a considerable 
degree of frustration; 
  
 
‘A typical night if you can describe the sleep as typical, is 
I go to bed around 10, 10:30,  I fall asleep straight away 
(clicks fingers) drop of a hat, head on the pillow and I’m 
away, I’ll sleep for 2 or 3 hours, then I’m up for between 
2  or  3  hours,   then   I’ll  sleep  for  2  hours   and   then 
I’m up’. 
 
Another  participant added; 
 
‘I can  sleep  I  can  go  to  off sleep  but  if I  don’t  take 
anything, I do lie awake, just lie awake or I get woken up 
this constant  being woken up is the worse thing’. 
 
Participants  described   that  when  they  woke  up 
during   the  night,   they  would   wake-up   suddenly, 
feeling very alert and this made  it difficult to try and 
go back to sleep; 
 
‘I go to bed about  10, I’m always tired  and I invariably 
90% of the time go straight to sleep and I will wake 1–2 
hours  later feeling as if it is time to get up’. 
 
 
Un-refreshing   sleep. In  the  morning   several  partici- 
pants also described  feeling un-refreshed which may 
be  a  result  of  the  disturbed sleep  throughout  the 
night; 
 
‘I’ve quite often woke up feeling more tired than when I 
went to bed’. 
 
 
Negative  thoughts and worry about sleep.  For  several 
participants, going to bed had become a negative 
experience   due   to  their   sleeping   difficulties,   and 
some participants reported developing negative 
thoughts  and expectations about sleep. Many had 
simply  resigned  themselves  to  the  belief  that  their 
sleep quality would be poor; 
 
‘If there’s something  on my mind,  that makes me a bit 
worried about sleeping, I don’t know what it is but I sort 
of need  to try and  get to the bottom  of it, but  I sort of 
have this fear of going to bed’. 
 
Four   participants  also  reported   that  they  often 
worry about  daily events and concerns  while lying in 
bed,  which may prevent  sleep onset; 
 
‘If you’re worried  about  one  of the  children  or there’s 
something  particular  you’re worried about.., you tend to 
sort of go over that in your mind’. 
 
Other  triggers of disturbed sleep were identified  as 
drinking   alcohol,   stress,   worry,  and   the  need   to 
urinate  during  the night. 
 
 
Theme 2: inter-relationship between symptoms 
 
Effect  of sleep  on symptoms.  Eleven  participants  felt 
that  a poor  nights sleep was directly associated  with 
reduced overall functioning the following day; 
‘There  is no typical day, I wake up  and  it depends  on 
what kind of sleep I’ve had, how broken  and how bad a 
night I’ve had’. 
 
Reduced coping  ability. The  majority  of participants 
felt  that  the  quality  of  their  sleep  was  related   to 
feelings of fatigue and pain. Three  participants 
elaborated that  they believed  that  feeling tired  after 
a  poor   nights   sleep  made   it  harder   to  cope  the 
following day, affecting their perceptions of pain; 
 
‘In some  ways it’s more  difficult because  I’m so tired  I 
don’t have the energy to cope with things, so I think they 
get me down a bit more’. 
 
 
Waking up due to the pain. Sitting  or lying for long 
periods  of time  was perceived  to  lead  to  increased 
pain  during  the  night  and  participants  often  high- 
lighted  that  they needed  to keep changing  positions 
or were restless at night to stay comfortable  in bed. 
Eleven  participants stated  that  being  in  pain  woke 
them  up during  the night; 
 
‘Lack of sleep affects your pain and er, and if you’re in a 
lot of pain and you roll over, the pain will wake you up’. 
 
 
Expectation. All of the participants interviewed had 
experienced disturbed  sleep  for  a number of years 
and almost expected to sleep poorly, especially if they 
were experiencing  high levels of pain and fatigue; 
 
‘You   almost   know,   that’s   psychological   again,   you 
almost  know you’ve had  a fairly bad  period  you’re not 
going to sleep well either or is it a fact?’ 
 
 
Theme 3: coping with disturbed  sleep 
 
Searching  for answers.  Little  information  had  been 
given  to  participants  from  health  professionals  on 
how to manage their FMS effectively. As a result, 
participants appeared  desperate  to seek answers and 
described  trying a whole range of things including 
mattresses  and pillows to improve their sleep quality; 
 
‘I put ear plugs in and I find when I put ear plugs in I seem 
to sleep different  . . . although  I don’t  like things  in my 
ears, if it means I’m going to sleep a bit better, so whether 
that’s about noise, although it’s very quiet where I live, so 
I don’t know, I think I’m just looking for answers.’ 
 
 
Rest and recuperation. To manage their symptoms  and 
engage  in  everyday  activities  participants described 
the need  to plan and  pace their  activities, including 
rest periods  throughout the day; 
 
‘It can be up to an hour, at least an hour, even if I didn’t 
sleep, I just have to get off my legs and just lie back and 
  
 
you know, very often I just lie back with nothing  on, no 
television,  nothing,  just, just alone’. 
 
Participants reported that extended  periods of 
inactivity  increased  levels of pain  and  muscle 
stiffness. Participants described  the need  to balance 
rest periods  with the need  to keep moving around; 
 
‘That’s  the  thing  about  fibromyalgia,  you  need  to  rest 
but at the same time you need  to move . . . you kind of 
just  want  to  stay in bed  or  whatever  but  you,  you  it’s 
hard but you need to keep moving but at the same time 
you need  to rest as well.’ 
 
Although two participants avoided napping  during 
the  day,  the  other  participants found  that  daytime 
naps  helped  to re-energise  them  particularly  if they 
were  feeling  fatigued   in  the  afternoons,  enabling 
them  to carry on with daily activities; 
 
‘I might have to go to bed for a couple of hours and then 
I’ll be alright for the evening, because I know they advise 
you not to go to bed don’t they, but I can’t physically not 
and I find it makes me feel better  actually if I do, so for 
me it works better,  so you I’ve learnt to do what suits me 
rather  than  what I’m told to do you know they say you 
muck up your body clock up if you sleep in the day but 
for me it doesn’t  work that way’. 
 
 
Nocturnal coping  strategies. On  awakening  at  night, 
participants described  utilising a range of approaches 
to  help  them   return   to  sleep.  Many   participants 
reported  keeping the light low and trying to relax in 
order to return  to sleep when they wake up too early; 
 
‘Sometimes  I think I can get back to sleep, so I wait to 
see if I can and I think come on and I just lie there and 
hopefully  I can  get back to sleep easily again,  um,  but 
more often than not, I can’t so after I try for about  15 to 
20 minutes  and if I can’t get back to sleep after that time 
then as I say I put the television on and it’ll refocus me 
and if I fall back to sleep, good’. 
 
However,  many participants reported  being awake 
for up  to  several hours  during  the  night  and  being 
unable  to get back to sleep; 
 
‘Oh I just get up, it’s just ridiculous  trying to sleep and 
you can’t sleep, you know you get to hate your bed after 
a while because you get fed up tossing around and trying 
to get to sleep the whole time’. 
 
 
Change to routine. Participants demonstrated a high 
level of awareness of the principles of sleep hygiene to 
aid sleep quality and many described avoiding large 
meals and stimulants  such as caffeine in the evening; 
 
‘I tend not to watch TV too late unless there’s something 
really good on but I try and make an effort, like I used to 
really like watching DVDs  late at night and now I don’t 
do that as much  or I’ll listen to the radio, it’s a bit more 
chilled  really,  yeah  drink  herb  tea  just  sort  of  wind 
down’. 
 
 
Medication as a last resort. Ten  participants had been 
prescribed  medication to aid sleep; however, parti- 
cipants reported being reluctant to take their 
medication – they had been discouraged from taking 
it by their clinicians – and  they said the effects were 
limited  in reducing  night-time  awakenings; 
 
‘I suppose  it helps a little bit but I wouldn’t  say it makes 
a tremendous difference you know, I suppose  I’d rather 
take it than take nothing,  any help is better than no help, 
but I still find myself waking up quite frequently every 
night’. 
 
 
Theme 4: impact on daily living 
 
‘A juggling act’. The concern  about trying to ensure a 
good   night’s   sleep  before   going  to  work  caused 
anxiety amongst  participants; 
 
‘The  not  sleeping  and  then  not  being  able to function 
the  next  day  when  you  need  to  perform  at  work . . . - 
when  you’re being paid and  you’re meant  to work and 
you  can’t   function,   it’s  horrible,   it’s  really  horrible 
because  you feel like a failure’. 
 
Effect  on others.  Participants were  concerned about 
the  impact   of  a  poor   nights   sleep  on  their   bed 
partners   and  the  pressure   this  placed  on  relation- 
ships; 
 
‘I think it was half the trouble  with my husband, I think 
it  caused  the  problem   there,  as  I  can  remember him 
saying oh you kept me awake by tossing and turning’. 
 
The  effect of a poor nights sleep also impacted  on 
families and friends through the need to cancel or 
reschedule  activities, rest and  nap  during  the day if 
their sleep had been disturbed; 
 
‘It does concern  me a lot, but they’ve adjusted  and they 
know  that  If I’m  bad  that  they’re  find  with  me  laying 
down, whereas before it would have been, they wouldn’t 
handle  it at all, you know,  but  now they just know it’s 
part of life really and that I need  to have a sleep’. 
 
 
Reduced spontaneity.  Participants described  the  need 
to  plan  and  pace  their  activities  to  manage   their 
pain  and  fatigue and  the  need  to schedule  in times 
to rest and  sleep caused  some  frustration  and 
resentment; 
 
‘All I know is, is that I never used to need a lot of sleep, 
never,  and  I now really resent  that  fact that  I need  so 
much,  I’m not saying my life is so exciting but when it’s, 
  
 
just now I think oh, I have to plan it round, oh can I have 
a lay in this weekend,  can I do this, can I do that, I find 
that very hard  to cope with’. 
 
The perceived impact of poor sleep on physical 
functioning also caused apprehension regarding life 
decisions   such   as  starting   a  new  job  with  early 
starting  hours  or having a baby; 
 
‘We’re wanting  to  start  a family,  so  that’s  kind  of an 
issue regarding sleep, actually; yes that’s a massive issue, 
because  we’ve been  wanting  to start  a family for ages, 
we’re not even doing that because  I don’t  think I could 
have that sort of sleep deprivation’. 
 
 
Discussion 
 
This   study   explored   participants’   experiences   of 
sleep  in  FMS.   Four   overarching   themes   emerged 
from the interviews: sleep disturbance, interrelation- 
ship between symptoms,  coping with disturbed sleep 
and impact on daily living. Poor sleep was revealed to 
be a core part of the symptom  experience  in FMS,  as 
coping with the sleep disturbance and striving to 
achieve a good night’s sleep dominated participants’ 
lives. 
Participants’  descriptions  of  experiencing   night- 
time  awakenings  and  restless  sleep  are  consistent 
with  previous  research  using  objective  measures  of 
sleep [21,22]. Many participants described  a pattern 
of sleep consisting of several blocks of sleep lasting 2– 
3 h during  the night  with periods  of wakefulness  in 
between. Participants found it difficult to find and 
maintain   a  comfortable   position  at  night  and  they 
were   often   woken   by  pain.   The   need   to   keep 
changing position to prevent pain, and stiffness also 
disrupted their  sleep.  The  perception of feeling un- 
refreshed after sleep appeared to result from the 
disrupted sleep pattern  and caused them the greatest 
concern. 
In contrast  to previous research  focusing on other 
chronic  pain conditions, the majority of participants 
in  this  study  did  not  report  difficulties  with  initial 
sleep   onset   when   they   first   went   to   bed   [35]. 
However,  participants stated  that  it was hard  to go 
back  to  sleep  when  they  woke-up  during  the  night 
and  described  feeling very alert on awakening.  This 
sleep  pattern   may  be  supportive  of a  hyperarousal 
model  of insomnia  [36].  This  model  proposes  that 
people with insomnia are more alert than would be 
expected  after  having  experienced poor  sleep.  This 
may be due to an increase in brain activity, basal and 
central nervous system metabolic rate and body 
temperature.  In  addition,  compensatory  strategies 
that  people  engage  in  when  they  experience   poor 
sleep, such as going to bed before the natural  decline 
in   body   temperature,   worrying   about    sleep   or 
ruminating  about   daily  events  may  also  have  an 
adverse effect on their sleep quality. Factors  believed 
to be linked to the aetiology of FMS such as 
dysregulation  of the hypothalamic-pituitary-adrenal 
(HPA)  axis are  also likely to  affect sleep  quality  in 
FMS  [37]. 
There   was  some  disparity   between   participants 
about  the most effective way to manage night time 
awakenings. Participants described  adopting  a wide 
range of strategies from using instrumental supports, 
cognitive coping approaches  and engaging in passive 
activities such as listening to relaxing music. Many 
participants had actively sought information and had 
often spent large sums of some of money trying to 
improve their sleep quality, even if there was little 
clinical evidence  of effectiveness.  It became  evident 
that all participants felt a loss of personal control over 
their sleep and were desperate  for answers. This may 
have resulted from the lack of information and support 
available on how to specifically manage FMS and sleep 
difficulties. Evidence from people experiencing pri- 
mary insomnia has revealed that non-pharmacological 
group  interventions including  the provision  of infor- 
mation  about  sleep and  application  of cognitive and 
behavioural   components,  can   effectively  improve 
sleep quality with benefits lasting over several years 
[36]. There  is increasing  evidence that cognitive and 
behavioural interventions may be beneficial to im- 
prove  sleep  quality  in  patients   with  chronic   pain 
[37,38], and it is likely these interventions may benefit 
people with FMS  and more methodologically robust 
clinical trials are required  [37]. 
Research  evidence  has  revealed  that  people  who 
engage  in  higher  levels of  exercise  have  improved 
sleep quality [39], and therefore  another  approach  to 
improve   sleep   quality   for   this   population  could 
involve  increasing  levels  of  activity  in  people  with 
FMS. However, research specifically exploring the 
effects of physical activity in FMS has rarely explored 
the  effect on sleep [40,41]  and  the  available results 
are inconsistent [42–44]. 
A strong theme  that emerged  in this study was the 
impact  of napping  during  the day on symptoms  and 
sleep quality. Many participants described  that when 
they  felt severely fatigued  during  the  day – usually 
mid  afternoon  – napping  was beneficial  in relieving 
pain  and  fatigue,  enabling  them  to  continue  their 
daily activities.  Napping  was often  actively planned 
into a daily schedule  if participants were planning  on 
going out in the evening or seeing friends and family 
to enable them to cope. Interestingly in this study 
participants reported that  they had  been  advised  to 
avoid napping  during  the day by health professionals 
because  of the negative effect daytime  napping  may 
have on subsequent sleep quality. This supports 
previous   findings   that   patients   with  chronic   pain 
report limited use of daytime napping [38,45]. In the 
  
 
general    population,   daytime    naps   of   530 min 
duration have been  found  to have beneficial  effects 
on excessive daytime sleepiness, mood  and cognitive 
performance [46–48].  However, current  clinical 
guidelines do not provide any specific guidance on 
managing  sleep disturbance [28] and clinical recom- 
mendations regarding  the use of daytime napping 
appear to be highly diverse. Previous research  on the 
effects of daytime napping have only been conducted 
in  people  without   underlying   medical   conditions, 
and   it  is  currently   unclear   as  to   whether   these 
findings  can  be  effectively applied  to  people  with 
FMS or other chronic pain and fatigue conditions. 
Therefore, further  research  exploring the use of 
daytime napping in patients with chronic pain and 
fatigue   conditions  including   FMS   is  needed   to 
inform  clinical guidelines. 
Despite  the high prevalence  of sleep difficulties in 
the participant sample, only half of the participants 
were taking medication to improve  their sleep. This 
may reflect that some patients  are reluctant  to ask for 
medical support about their sleep difficulties or 
alternatively  that  clinicians  may not  see treating  the 
sleep difficulties with medication as necessary or 
appropriate. Interestingly, the half of the participants 
who  had  been  prescribed  hypnotic  medication 
described  feeling  reluctant  to  use  it.  This  was due 
to  being  discouraged  by  their  clinicians,  concerns 
that  their  prescription may  not  be  renewed  if they 
used  too much  and  perceptions that  the medication 
had limited effectiveness. Participants also stated that 
as their sleep was often unpredictable, it was difficult 
to  know  when  they  would  need  to  take  the 
medication (as they are usually required  to take the 
medication an  hour  before  going  to  bed).  Partici- 
pants described  that they mainly felt the need for the 
medication in the early hours of the morning  to help 
them get back to sleep after a particularly disrupted 
night.  The  use  of pregabalin  and  gabapentin have 
been found to significantly improve pain and sleep 
quality in FMS [49–51]; however, this study revealed 
that participants taking these medications still 
experienced significant sleep disturbance that dis- 
rupted  their daily lives, supporting the need for a 
multifaceted treatment approach. 
The ability to generalise the findings from this study 
may be reduced as the small sample  of participants 
were  recruited  from   patient   support   groups   and 
the  sample  may  therefore  not  be  representative of 
the population of people with FMS.  However, one of 
the aims of IPA is to identify a relevant homogenous 
sample for the research question to conduct a detailed 
exploration  of the research  question  and  the indivi- 
dual experience.  Variations in sleep quality may exist 
between patients with different degrees of disease 
severity or due to other aspects of patients’ history and 
further study is needed. 
It is of concern  that three participants described 
experiences  that  were indicative  of a sleep disorder 
that  had  been  undiagnosed and  it  became  evident 
that they had not undergone any screening or 
investigation.  Some  sleep  disorders  with  an  under- 
lying physical cause such as sleep apnea can be 
effectively  managed   using   specific  medical   treat- 
ments   once  diagnosed   [52].   The   findings  of  this 
support  the European League against Rheumatism 
(EULAR)   recommendations,  suggesting   that   pa- 
tients  should  be screened  for sleep disorders  as part 
of clinical evaluation. 
The  European League  against  Rheumatism (EU- 
LAR)  recommends that  due  to  the  complexity  of 
FMS,  comprehensive evaluations  including  analysis 
of  sleep  quality  are  needed   to  identify  individual 
needs.  Optimal  treatment of FMS  should  then  be 
based   on  a  multidisciplinary  approach   (including 
both non-pharmacological and pharmacological in- 
terventions)  tailored   to  the  identified   needs   [21]. 
These findings strengthen the increasing body of 
evidence that sleep quality plays an important role in 
the exacerbation of symptoms  in FMS  [22]. 
 
Conclusion 
 
People  with FMS  find that  sleep difficulties are one 
of the most challenging symptoms to cope with, since 
exacerbation of pain,  fatigue  and  cognitive  difficul- 
ties seem to be strongly related  to poor sleep. 
Awakening at night in a high state of arousal  after a 
short  block  of  sleep  is  the  most  disruptive   sleep 
problem.  Recommendations specially addressed to 
patients  with FMS  on  how to identify  and  manage 
sleep disturbance need to be included  into clinical 
management guidelines. 
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